Hospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

    Breast, Vol. 77

2022

  1. Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

    Frontiers in Oncology, Vol. 11

2019

  1. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

    Therapeutic Advances in Medical Oncology, Vol. 11

  2. Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)

    Scientific Reports, Vol. 9, Núm. 1